Shenzhen Net Receivables vs Total Liab Analysis

002551 Stock

3.43 0.03 0.88%

Shenzhen Glory financial indicator trend analysis is much more than just breaking down Shenzhen Glory Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shenzhen Glory Medical is a good investment. Please check the relationship between Shenzhen Glory Net Receivables and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Net Receivables vs Total Liab

Net Receivables vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shenzhen Glory Medical Net Receivables account and Total Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Shenzhen Glory's Net Receivables and Total Liab is 0.91. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Liab in the same time period over historical financial statements of Shenzhen Glory Medical, assuming nothing else is changed. The correlation between historical values of Shenzhen Glory's Net Receivables and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Shenzhen Glory Medical are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Net Receivables i.e., Shenzhen Glory's Net Receivables and Total Liab go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Receivables

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Shenzhen Glory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shenzhen Glory Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 103.2 M. The current year's Tax Provision is expected to grow to about 31.4 M

	2022	2023	2024	2025 (projected)
Gross Profit	221.9M	197.6M	177.8M	319.4M
Research Development	48.2M	40.1M	46.1M	52.2M

Gross Profit Research Development

Shenzhen Glory fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.73	0.07	0.8	0.94	0.58	0.87	0.71	0.25	0.95	0.7	0.36	0.97	0.62	0.63	0.61	0.76	0.71	0.84	0.42	0.77	0.9	0.94	0.42	0.81	0.85
Short Long Term Debt Total	0.73		-0.11	0.48	0.59	0.35	0.75	0.4	0.56	0.69	0.47	0.23	0.7	0.54	0.95	0.5	0.52	0.96	0.52	0.36	0.37	0.76	0.68	0.31	0.52	0.57
Other Current Liab	0.07	-0.11		0.31	-0.02	0.3	0.15	-0.4	0.14	0.07	0.36	-0.31	0.03	-0.14	-0.17	-0.31	0.37	-0.13	0.14	0.32	-0.08	0.18	0.12	0.32	0.35	-0.08
Total Current Liabilities	0.8	0.48	0.31		0.6	0.76	0.73	0.56	0.29	0.75	0.97	0.09	0.7	0.48	0.29	0.14	0.97	0.4	0.76	0.78	0.37	0.93	0.86	0.77	0.61	0.58
Total Stockholder Equity	0.94	0.59	-0.02	0.6		0.39	0.75	0.74	0.09	0.88	0.45	0.43	0.95	0.53	0.56	0.74	0.52	0.63	0.8	0.16	0.93	0.71	0.83	0.15	0.81	0.87
Other Liab	0.58	0.35	0.3	0.76	0.39		0.35	0.41	0.31	0.45	0.72	-0.06	0.51	0.1	0.3	0.04	0.74	0.39	0.51	0.6	0.3	0.74	0.61	0.59	0.51	0.36
Property Plant And Equipment Net	0.87	0.75	0.15	0.73	0.75	0.35		0.45	0.32	0.9	0.72	0.29	0.85	0.72	0.62	0.44	0.76	0.67	0.63	0.43	0.5	0.83	0.82	0.46	0.62	0.72
Current Deferred Revenue	0.71	0.4	-0.4	0.56	0.74	0.41	0.45		0.18	0.66	0.39	0.22	0.72	0.36	0.37	0.46	0.42	0.43	0.7	0.17	0.66	0.6	0.62	0.11	0.56	0.83
Net Debt	0.25	0.56	0.14	0.29	0.09	0.31	0.32	0.18		0.18	0.3	-0.67	0.34	-0.05	0.54	-0.33	0.27	0.56	0.31	0.31	-0.13	0.45	0.1	0.15	0.43	0.33
Retained Earnings	0.95	0.69	0.07	0.75	0.88	0.45	0.9	0.66	0.18		0.65	0.41	0.92	0.79	0.57	0.59	0.74	0.64	0.71	0.4	0.68	0.84	0.89	0.43	0.71	0.78
Accounts Payable	0.7	0.47	0.36	0.97	0.45	0.72	0.72	0.39	0.3	0.65		0.06	0.59	0.44	0.28	0.05	0.97	0.37	0.65	0.77	0.22	0.89	0.79	0.78	0.5	0.46
Cash	0.36	0.23	-0.31	0.09	0.43	-0.06	0.29	0.22	-0.67	0.41	0.06		0.24	0.51	0.21	0.85	0.13	0.2	0.11	-0.08	0.5	0.15	0.49	0.06	-0.04	0.19
Non Current Assets Total	0.97	0.7	0.03	0.7	0.95	0.51	0.85	0.72	0.34	0.92	0.59	0.24		0.58	0.66	0.57	0.63	0.72	0.8	0.27	0.78	0.83	0.82	0.26	0.85	0.88
Other Assets	0.62	0.54	-0.14	0.48	0.53	0.1	0.72	0.36	-0.05	0.79	0.44	0.51	0.58		0.4	0.46	0.53	0.42	0.3	0.33	0.3	0.54	0.62	0.45	0.2	0.34
Long Term Debt	0.63	0.95	-0.17	0.29	0.56	0.3	0.62	0.37	0.54	0.57	0.28	0.21	0.66	0.4		0.55	0.32	0.99	0.43	0.09	0.41	0.63	0.54	0.04	0.51	0.53
Cash And Short Term Investments	0.61	0.5	-0.31	0.14	0.74	0.04	0.44	0.46	-0.33	0.59	0.05	0.85	0.57	0.46	0.55		0.12	0.54	0.4	-0.18	0.8	0.33	0.6	-0.13	0.38	0.52
Net Receivables	0.76	0.52	0.37	0.97	0.52	0.74	0.76	0.42	0.27	0.74	0.97	0.13	0.63	0.53	0.32	0.12		0.41	0.63	0.82	0.28	0.91	0.85	0.82	0.5	0.5
Non Current Liabilities Total	0.71	0.96	-0.13	0.4	0.63	0.39	0.67	0.43	0.56	0.64	0.37	0.2	0.72	0.42	0.99	0.54	0.41		0.52	0.18	0.47	0.71	0.62	0.12	0.58	0.59
Inventory	0.84	0.52	0.14	0.76	0.8	0.51	0.63	0.7	0.31	0.71	0.65	0.11	0.8	0.3	0.43	0.4	0.63	0.52		0.4	0.69	0.8	0.8	0.35	0.83	0.77
Other Current Assets	0.42	0.36	0.32	0.78	0.16	0.6	0.43	0.17	0.31	0.4	0.77	-0.08	0.27	0.33	0.09	-0.18	0.82	0.18	0.4		-0.06	0.67	0.58	0.94	0.25	0.15
Other Stockholder Equity	0.77	0.37	-0.08	0.37	0.93	0.3	0.5	0.66	-0.13	0.68	0.22	0.5	0.78	0.3	0.41	0.8	0.28	0.47	0.69	-0.06		0.48	0.67	-0.08	0.7	0.76
Total Liab	0.9	0.76	0.18	0.93	0.71	0.74	0.83	0.6	0.45	0.84	0.89	0.15	0.83	0.54	0.63	0.33	0.91	0.71	0.8	0.67	0.48		0.91	0.64	0.71	0.69
Total Current Assets	0.94	0.68	0.12	0.86	0.83	0.61	0.82	0.62	0.1	0.89	0.79	0.49	0.82	0.62	0.54	0.6	0.85	0.62	0.8	0.58	0.67	0.91		0.59	0.66	0.71
Short Term Debt	0.42	0.31	0.32	0.77	0.15	0.59	0.46	0.11	0.15	0.43	0.78	0.06	0.26	0.45	0.04	-0.13	0.82	0.12	0.35	0.94	-0.08	0.64	0.59		0.17	0.07
Intangible Assets	0.81	0.52	0.35	0.61	0.81	0.51	0.62	0.56	0.43	0.71	0.5	-0.04	0.85	0.2	0.51	0.38	0.5	0.58	0.83	0.25	0.7	0.71	0.66	0.17		0.79
Common Stock	0.85	0.57	-0.08	0.58	0.87	0.36	0.72	0.83	0.33	0.78	0.46	0.19	0.88	0.34	0.53	0.52	0.5	0.59	0.77	0.15	0.76	0.69	0.71	0.07	0.79

Click cells to compare fundamentals

Shenzhen Glory Account Relationship Matchups

Shenzhen Glory fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	5.1B	5.0B	4.3B	3.9B	4.5B	3.0B
Short Long Term Debt Total	479.9M	392.2M	332.1M	290.6M	334.2M	248.1M
Other Current Liab	5.1M	7.5M	237.1M	24.2M	27.8M	26.4M
Total Current Liabilities	1.0B	1.1B	882.2M	829.8M	954.3M	821.5M
Total Stockholder Equity	3.0B	3.1B	2.8B	2.6B	3.0B	1.8B
Other Liab	72.8M	76.3M	86.3M	88.4M	101.7M	67.3M
Property Plant And Equipment Net	785.1M	637.6M	556.0M	488.8M	562.1M	483.0M
Current Deferred Revenue	387.8M	593.8M	223.6M	402.7M	463.1M	486.3M
Net Debt	(663.4M)	(404.2M)	(153.2M)	(199.7M)	(179.7M)	(188.7M)
Retained Earnings	772.1M	829.7M	578.7M	429.8M	494.3M	435.3M
Accounts Payable	466.9M	447.1M	380.0M	381.9M	439.1M	418.5M
Cash	1.1B	796.4M	485.2M	490.3M	563.9M	584.5M
Non Current Assets Total	2.5B	2.6B	2.2B	2.1B	2.4B	1.3B
Other Assets	849.4M	1.1B	1.2B	1.0	1.15	1.09
Long Term Debt	301.2M	331.1M	290.6M	269.5M	310.0M	188.2M
Cash And Short Term Investments	1.3B	1.1B	920.1M	818.2M	940.9M	679.8M
Net Receivables	904.1M	871.2M	653.9M	611.0M	702.7M	714.2M
Liabilities And Stockholders Equity	5.1B	5.0B	4.3B	3.9B	4.5B	3.0B
Non Current Liabilities Total	377.4M	417.4M	379.0M	354.2M	407.3M	227.7M
Inventory	343.7M	375.9M	416.8M	371.5M	427.3M	254.1M
Other Current Assets	99.0M	57.4M	37.4M	21.9M	25.2M	23.9M
Other Stockholder Equity	1.3B	1.4B	1.3B	1.3B	1.5B	836.2M
Total Liab	1.4B	1.5B	1.3B	1.2B	1.4B	1.0B
Total Current Assets	2.6B	2.4B	2.0B	1.8B	2.1B	1.7B
Short Term Debt	178.7M	61.1M	41.5M	21.1M	24.2M	23.0M
Intangible Assets	217.2M	275.6M	510.0M	280.4M	322.4M	173.5M
Common Stock	820.3M	844.7M	844.8M	844.8M	971.5M	1.0B
Property Plant Equipment	987.8M	785.1M	637.6M	556.0M	639.4M	486.3M
Non Currrent Assets Other	1.2B	1.4B	1.3B	1.4B	1.6B	1.7B
Short Term Investments	121.1M	292.5M	434.9M	327.9M	377.1M	395.9M
Net Tangible Assets	2.0B	2.7B	2.8B	2.2B	2.6B	2.2B
Deferred Long Term Liab	7.4M	13.5M	10.9M	6.5M	7.5M	8.4M
Short Long Term Debt	74.1M	138.9M	51.3M	1.9M	1.7M	1.6M
Common Stock Shares Outstanding	820.3M	844.7M	844.8M	844.8M	971.5M	859.9M
Net Invested Capital	3.4B	3.5B	3.0B	2.9B	3.3B	3.3B
Net Working Capital	1.6B	1.3B	1.1B	992.9M	1.1B	1.3B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Other Information on Investing in Shenzhen Stock

Balance Sheet is a snapshot of the financial position of Shenzhen Glory Medical at a specified time, usually calculated after every quarter, six months, or one year. Shenzhen Glory Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Shenzhen Glory and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Shenzhen currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shenzhen Net Receivables vs Total Liab Analysis

Net Receivables vs Total Liab

Net Receivables vs Total Liab Correlation Analysis

Correlation Coefficient

Net Receivables

Total Liab

Shenzhen Glory fundamental ratios Correlations

Shenzhen Glory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shenzhen Glory fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Shenzhen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 0.99	Long Term Debt
Non Current Assets Total	+ 0.97	Total Assets
Accounts Payable	+ 0.97	Total Current Liabilities
Net Receivables	+ 0.97	Total Current Liabilities
Net Receivables	+ 0.97	Accounts Payable
Non Current Liabilities Total	+ 0.96	Short Long Term Debt Total

Cash	- 0.67	Net Debt
Current Deferred Revenue	- 0.4	Other Current Liab
Cash And Short Term Investments	- 0.33	Net Debt
Cash And Short Term Investments	- 0.31	Other Current Liab
Cash	- 0.31	Other Current Liab
Other Current Assets	- 0.18	Cash And Short Term Investments